What better way to implement human asset management systems in the launch of corporate parental rights than with a press release of a new capital venture of predicting what you will be when you grow up.
Could AI take control of human birth?
This is strictly to maximize profits, of course, in the creative billing to Medicaid for child welfare research and design of socioeconomic policies, of which Michigan is ground zero in pilot testing.
This is the industry propaganda of the distractionary pro life narrative.
Infant mortality is just another method in the acquisition of goods for the corporate parent, where the Michigan legislative side is at full steam ahead.
Keep in mind, when a mother has no access to health care, or quality living, or food, or education, infant mortality becomes geographically statistically significant, like in Detroit, where no one has yet to comment on what happens to those placentas or pre-term births.
A fetus is considered an organ, and you know what people do with organs, and other tissues, and RNA, and DNA.
AI data collection at birth is a great way of
And I almost forgot, the venture capital part are those Social Impact Bonds in child welfare NGOs.
NOTE TO SELF: MAP OUT THESE MODELS
AI enters the delivery room
Silicon Valley has paired artificial intelligence with the everyday iPad to track blood loss experienced by mothers during delivery.
Of all the reasons to visit a hospital, childbirth may be the absolute best.
The goal is to have mom and baby return home as soon as possible, happy and healthy.
Unfortunately, even in the 21st century, this isn’t always the case. Risk is inherent in the birth process.
Would you be surprised to learn that maternal mortality rates in the U.S. are headed in the wrong direction? It’s true.
According to the CDC, the rate of pregnancy-related deaths in the U.S. has been worsening for some time, jumping from 7.2 deaths per 100,000 live births in 1987 to 18 deaths per 100,000 live births in 2014.
To improve birth outcomes, hospitals have turned to 21st century innovations.
Precision measurement
In childbirth, there is always some blood loss on the part of the mother, not just during delivery but during postpartum recovery, too.
This can sometimes become a major concern, given that hemorrhaging is a leading cause of pregnancy-related death in the U.S.
Consequently, it’s vital to get detailed information about the volume of blood loss during vaginal deliveries and during C-sections, as it helps providers take quick and appropriate action when the moment demands.
Gauss Surgical, a Silicon Valley-based company, has developed technology to improve this process.
The company’s Gauss Triton system pairs artificial intelligence with a readily available iPad to give providers estimates of a mother’s blood loss.
The Triton app, downloaded directly to the iPad, can analyze visually and materially.
In instances of vaginal delivery, the Triton system can calculate for blood loss by weighing the blood-absorbent items that are used during delivery. The software effectively analyzes the weight of the used items and compares this to the pre-surgery weight of the items. With each hospital system using specific brands and sizes of sponges or swabs, it allows the software to make highly detailed assessments.
In C-section deliveries, the technology is all the more fascinating.
The doctor or nurse can point an iPad camera at the sponges or swabs used to clean blood and snap a photograph, allowing the system to scrutinize the image for hemoglobin and blood content.
The AI at work in this case is much like the AI used in facial recognition, only instead of analyzing faces, the system analyzes a blood-soaked swab or sponge.
Providers can immediately assess that data, helping them accurately monitor blood loss volume.
Altogether, the system is a tremendous upgrade from the approaches of yesteryear.
“Traditionally, we have weighed blood-soaked items to estimate how much blood has been lost,” said Carolyn Leja, CNM, director of women’s and infant services at Spectrum Health.
That approach had its obvious weaknesses, particularly in overestimating or underestimating blood loss. (It’s difficult, for example, to visually distinguish blood from other fluids on a sponge.)
The response to blood loss during delivery can depend on timing—how far along in the delivery process things have progressed if a problem arises. Where one response mandates medication as a method to slow delivery, another may require a blood transfusion.
More accuracy at the right time can lead to more precise responses, something the Gauss system helps providers achieve at critical moments.
By quickly identifying instances of hemorrhage, for example, the technology may reduce the need for blood transfusions and shorten a patient’s length of stay.
“The scanning technology helps assure that we are intervening at the right point,” Leja said. “This tells us within a few CCs how we are doing.”
Smarter AI
Spectrum Health Butterworth Hospital has been using the Triton technology since December. The weight system is used in normal deliveries and the optical system is used in C-sections. It’s the first hospital in Michigan to use the new technology.
Spectrum Health Ventures is one of 10 investors in Gauss Surgical’s Triton artificial intelligence technology.
The larger plan is to incorporate the technology into all labor and delivery rooms.
“We worry about blood hemorrhages,” said David Colombo, MD, chief of Spectrum Health Maternal Fetal Medicine. “Young healthy people giving birth don’t consider risks, but we treat every case with potential risks in mind. When you talk about a patient hemorrhaging, well, this is the stuff we lose sleep over.”
As with many things involving today’s species of artificial intelligence, it is nothing short of remarkable.
Any technology that enhances the delivery process and improves patient care—particularly by perfecting data collection and reporting—is a useful addition to the health care environment.
“There are lots of steps we can take,” Leja said. “We just want to be prepared for every delivery.”
Learn more about Spectrum Health Ventures.
Now, meet your Traffickers of Tiny Humans of Spectrum Health, because it all started in child welfare because no one cares.
These are the purveyors of predictive modeling crap.
These are the faces behind infant mortality in Michigan, and they used Medicaid fraud in child welfare to build this artificial Behemoth of using children of "The Poors" for human subject research and design testing as lab rats, based upon the antiquities of chattel law, whereby, the re-engineering of parental rights in a spectacular transmogrification of chattel law for corporations.
This is the privatization model, replete with nifty new and improved terms for human trafficking.
Please, familiarize yourselves with the latest terminologies in the trafficking of tiny humans, or, more intuitively understood as modern day industry of the residuals of the peculiar institution.
These are the privateers who have raided the children's trusts, our most precious treasures.
Roger Jansen, PhD, is senior vice president and chief strategy officer at Spectrum Health, a leading integrated health system based in Grand Rapids, Michigan. He has extensive clinical practice, executive management, strategic, business development, M&A and organizational development experience. Roger has led organizations through transformational change, fostered diverse growth and revenue strategies, and spearheaded innovation teams and strategic partnerships to achieve substantial and sustainable growth.
Prior to joining Spectrum Health in August 2011, Roger was CEO of ThinkWise Inc., an organizational development, consulting and technology company in Grand Rapids, Mich. Roger also led Leadership Capital Group, which provided strategic, executive management, mergers and acquisitions, organizational design and human capital planning and consulting efforts to Fortune 500 and family-owned companies internationally. Roger completed his PhD with training in clinical and neuropsychological assessment at the University of Illinois at Chicago and his undergraduate work in psychology and biology at Michigan State University.
Roger’s entrepreneurial experience includes forming two technology companies that remain based in West Michigan. Roger has received regional and national recognition as one of the Most Innovative Business Executives in the Midwest and as one of the Top 10 Chief Human Resource Officers in the country.
Roger’s entrepreneurial experience includes forming two technology companies that remain based in West Michigan. Roger has received regional and national recognition as one of the Most Innovative Business Executives in the Midwest and as one of the Top 10 Chief Human Resource Officers in the country.
Scott McLean
Scott McLean is the executive director for Spectrum Health Ventures. His responsibilities include development of syndicate partners; investment review, due diligence, valuation and structuring; communication and coordination with the SHV advisory board; portfolio governance; and providing financial updates to Spectrum Health’s executive team. He also maintains relations with the portfolio’s investments and syndicate partners.
Scott has a diverse background in corporate finance and private equity investing along with substantial entrepreneurial experience having started and operated a number of companies. Most recently Scott was a partner in NH Learning Solutions, Livonia, Mich., one of the country’s largest providers of IT certification training. As COO, he led the company through substantial growth both organically and through a series of acquisitions, nearly doubling the size of the organization. As chief school administrator he restructured the consumer education division and developed significant new revenue streams in addition to putting the school on track for national accreditation. Prior to that, Scott was involved with investments in ThinkWise, Grand Rapids, Mich.; Revue Media, Grand Rapids, Mich.; Best Source Publishing, Grand Rapids, Mich. and Denver, Colo.; and Falding Capital Group, Grand Rapids, Mich.
Scott began his career as a Certified Public Accountant with Arthur Andersen following graduation from Michigan State University. Outside of SHV, Scott is a board member for NH Learning Solutions, ThinkWise, The Employers Association and West Michigan Works.
Scott Lancaster, MD, MBA
Clinical Director
Scott Lancaster, MD, MBA, is the clinical director and a general partner with Spectrum Health Ventures. He joined the team in June 2017.
In the current health care business and economic climate, successful organizations have to be cognizant of disruptive threats that place the core business at risk and act on both short-term and long-range investment opportunities to counteract these forces. In his position at SHV, Scott discovers and investigates such opportunities for Spectrum Health. With his years of clinical practice experience and business acumen, he helps the system identify potential strategic fits and also works extensively with clinical teams on due diligence.
Scott practiced radiology for 18 years in Grand Rapids and held various roles as an officer and director of Advanced Radiology Services, the leading radiology physician specialty group in West Michigan. He earned an MBA from the Stephen M. Ross School of Business at the University of Michigan. Scott received his undergraduate degree from the University of Michigan and his medical degree from the Michigan State University College of Human Medicine. He completed his Residency in Diagnostic Radiology at Henry Ford Hospital and then completed his Fellowship in Musculoskeletal Imaging at the University of Michigan in Ann Arbor. Dr. Lancaster is board certified by the American Board of Radiology.
Target Segments <===Targeted Case Management - Medicaid
✓ Access Solutions
✓ Population & Health Analytics
✓ Genomics & Precision Medicine
✓ Artificial Intelligence & Cognitive Computing
✓ Consumer Wellness & Behavioral Health
✓ Health-Related Products & Services
Voting is beautiful, be beautiful ~ vote.©
No comments:
Post a Comment